公开(公告)号：US20220023614A1

公开(公告)日：2022-01-27

申请号：US17496719

申请日：2021-10-07

申请人： Aria CV, Inc.

发明人： Karl VOLLMERS ,  Lynn ZWIERS ,  John GAINOR ,  John SCANDURRA

IPC分类号： A61M60/869 ,  A61M60/268 ,  A61M60/122 ,  A61M60/135 ,  A61M60/00 ,  A61M60/274 ,  A61B17/12 ,  A61M1/00 ,  A61M29/02 ,  C01B17/00 ,  C01B17/45

摘要： Diffusion and infusion resistant implantable devices and methods for reducing pulsatile pressure are provided. The implantable device includes a balloon implantable within a blood vessel of a patient, e.g., the pulmonary artery. The balloon is injected with a fluid mixture comprising a constituent fluid(s) and a diffusion-resistant gas to provide optimal balloon volume and limit fluid diffusion throughout multiple cardiac cycles. The fluid mixture may be pressurized such that the balloon is transitionable between an expanded state and a collapsed state responsive to pressure fluctuations in the blood vessel.

公开(公告)号：US20240181241A1

公开(公告)日：2024-06-06

申请号：US18528599

申请日：2023-12-04

申请人： Aria CV, Inc.

发明人： Karl VOLLMERS ,  Lynn ZWIERS ,  John GAINOR ,  John SCANDURRA

IPC分类号： A61M60/869 ,  A61B17/00 ,  A61B17/12 ,  A61M1/00 ,  A61M29/02 ,  A61M60/00 ,  A61M60/122 ,  A61M60/135 ,  A61M60/268 ,  A61M60/274 ,  C01B17/00 ,  C01B17/45

CPC分类号： A61M60/869 ,  A61B17/12022 ,  A61B17/12027 ,  A61B17/12036 ,  A61B17/12109 ,  A61B17/12131 ,  A61B17/12136 ,  A61M1/00 ,  A61M29/02 ,  A61M60/00 ,  A61M60/122 ,  A61M60/135 ,  A61M60/268 ,  A61M60/274 ,  C01B17/00 ,  C01B17/45 ,  C01B17/4507 ,  C01B17/4515 ,  C01B17/453 ,  A61B2017/00535 ,  A61B2017/00557 ,  A61M2202/0208 ,  A61M2202/0225 ,  A61M2202/025 ,  A61M2202/04

摘要： Diffusion and infusion resistant implantable devices and methods for reducing pulsatile pressure are provided. The implantable device includes a balloon implantable within a blood vessel of a patient, e.g., the pulmonary artery. The balloon is injected with a fluid mixture comprising a constituent fluid(s) and a diffusion-resistant gas to provide optimal balloon volume and limit fluid diffusion throughout multiple cardiac cycles. The fluid mixture may be pressurized such that the balloon is transitionable between an expanded state and a collapsed state responsive to pressure fluctuations in the blood vessel.

公开(公告)号：US20200046369A1

公开(公告)日：2020-02-13

申请号：US16342968

申请日：2017-10-17

申请人： Aria CV, Inc.

发明人： John GAINOR ,  Karl VOLLMERS ,  John SCANDURRA ,  Lucas HARDER ,  Piramiah ELAYAPERUMAL

IPC分类号： A61B17/12 ,  A61L29/12 ,  A61M39/02

摘要： A device for reducing pulsatile pressure within a vessel to treat heart disease, such as pulmonary hypertension, includes a compliant body structured to expand and contract upon changes in pressure within the vessel, a reservoir structured for holding a fluid therein, and a conduit extending between and fluidly coupling the reservoir and the compliant body, wherein the device includes a graphene-polymer composite designed to resist diffusion of the fluid through the device.

公开(公告)号：US20210402159A1

公开(公告)日：2021-12-30

申请号：US17356410

申请日：2021-06-23

申请人： Aria CV, Inc.

发明人： Lucas HARDER ,  Lynn ZWIERS ,  Karl VOLLMERS ,  John SCANDURRA ,  John GAINOR ,  Hendrik de Hoog ,  Marc Knutson ,  Katherine SOOJIAN ,  Miles WING

IPC分类号： A61M25/10 ,  A61F2/95

摘要： An implantable device for reducing pulsatile pressure within a blood vessel is described herein, for example to treat pulmonary hypertension. The implantable device may include a fluid reservoir, a compliant member (e.g., a balloon), and a conduit coupled to the fluid reservoir and the compliant member. Advanced designs for anchoring the compliant member in the blood vessel are described. In addition, enhanced reservoir, conduit, and balloon designs, as well as methods for implanting/using the same, are provided.

公开(公告)号：US20210069396A1

公开(公告)日：2021-03-11

申请号：US17011870

申请日：2020-09-03

申请人： Aria CV, Inc.

发明人： Karl VOLLMERS ,  Lynn ZWIERS ,  John GAINOR ,  John SCANDURRA

IPC分类号： A61M1/10 ,  A61M1/12 ,  C01B17/45

摘要： Diffusion and infusion resistant implantable devices and methods for reducing pulsatile pressure are provided. The implantable device includes a balloon implantable within a blood vessel of a patient, e.g., the pulmonary artery. The balloon is injected with a fluid mixture comprising a constituent fluid(s) and a diffusion-resistant gas to provide optimal balloon volume and limit fluid diffusion throughout multiple cardiac cycles. The fluid mixture may be pressurized such that the balloon is transitionable between an expanded state and a collapsed state responsive to pressure fluctuations in the blood vessel.